All Stories

  1. HEAT STRESS AND NEUROLOGICAL BIOMARKERS IN OUTDOOR WORKERS: A CROSS-SECTIONAL OBSERVATIONAL STUDY
  2. Work Productivity Loss in People Living With Long COVID Symptoms: a good start and a missed opportunity
  3. European neurologists need to be aware of chikungunya (CHIKV) and dengue (DENV) viruses
  4. CT Perfusion Changes in Ischemic Stroke Due to Isolated Internal Carotid Artery Occlusions: From Severity Assessment to Therapy
  5. Occupational zoonoses, neurological diseases, and public health: A one health approach
  6. EBV and Molecular Mimicry: Therapeutic Implications
  7. Immune Response Against SARS-CoV-2
  8. Comparison of dry and wet electroencephalography for the assessment of cognitive evoked potentials and sensor-level connectivity
  9. Brain oscillatory processes related to sequence memory in healthy older adults
  10. Psychological General Well-being, Cognitive Failure, and Inflammation Biomarkers Among Workers 4 Months After a Mild/Asymptomatic SARS-CoV-2 Infection
  11. Brain oscillatory processes related to sequence memory in healthy older adults
  12. Intensive Social Interaction for Treatment of Poststroke Depression in Subacute Aphasia: The CONNECT Trial
  13. Anti-neuronal antibodies against brainstem antigens are associated with COVID-19
  14. Seroprevalence of vector-borne pathogens in outdoor workers from southern Italy and associated occupational risk factors
  15. Impact of COVID-19 emergency on the psychological well-being of susceptible individuals
  16. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection
  17. Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein
  18. Publisher Correction: Epitopes for a 2019-nCoV vaccine
  19. An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines
  20. COVID19 outbreak in Lombardy, Italy: An analysis on the short-term relationship between air pollution, climatic factors and the susceptibility to SARS-CoV-2 infection
  21. Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry
  22. Increased Recruitment of Domain-General Neural Networks in Language Processing Following Intensive Language-Action Therapy: fMRI Evidence From People With Chronic Aphasia
  23. Cerebrospinal fluid findings in COVID-19 indicate autoimmunity
  24. SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism
  25. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons
  26. A Peptide Link Between Human Cytomegalovirus Infection, Neuronal Migration, and Psychosis
  27. Epitopes for a 2019-nCoV vaccine
  28. COVID-19 Outbreak in Lombardy, Italy: An Analysis of the Short-Term Role of Air Pollution and Meteorological Factors
  29. Herpesviruses, autoimmunity and epilepsy: Peptide sharing and potential cross-reactivity with human synaptic proteins
  30. Cross-Reactivity as a Mechanism Linking Infections to Stroke
  31. Cytomegalovirus Infection: The Neurodevelopmental Peptide Signatures
  32. Peptide Sharing Between Viruses and DLX Proteins: A Potential Cross-Reactivity Pathway to Neuropsychiatric Disorders
  33. Efficacy of intensive aphasia therapy in patients with chronic stroke: a randomised controlled trial
  34. The Guillain–Barrè peptide signatures: from Zika virus to Campylobacter, and beyond
  35. Communicative-Pragmatic Assessment Is Sensitive and Time-Effective in Measuring the Outcome of Aphasia Therapy
  36. From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between Toxoplasma gondii and N-Methyl-d-Aspartate Receptors As a Potential Mechanistic Link
  37. Electrophysiological Evidence for Early and Interactive Symbol Access and Rule Processing in Retrieving and Combining Language Constructions
  38. A Spiking Neurocomputational Model of High-Frequency Oscillatory Brain Responses to Words and Pseudowords
  39. Therapy-Induced Neuroplasticity of Language in Chronic Post Stroke Aphasia: A Mismatch Negativity Study of (A)Grammatical and Meaningful/less Mini-Constructions
  40. Using language for social interaction: Communication mechanisms promote recovery from chronic non-fluent aphasia
  41. Minimal immune determinants connect Zika virus, human Cytomegalovirus, andToxoplasma gondiito microcephaly-related human proteins
  42. Reply concerning the article “Zika virus and autoimmunity: From microcephaly to Guillain–Barré syndrome, and beyond”
  43. Zika virus and autoimmunity: From microcephaly to Guillain-Barré syndrome, and beyond
  44. Understanding Neuropsychiatric Diseases, Analyzing the Peptide Sharing between Infectious Agents and the Language-Associated NMDA 2A Protein
  45. Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B
  46. H1N1 versus H5N1 hemagglutinins: A possible differential immunologic impact on neurodevelopment
  47. EBV-Associated Cancer and Autoimmunity: Searching for Therapies
  48. Single Amino Acid Repeats Connect Viruses to Neurodegeneration
  49. The Peptide Network between Tetanus Toxin and Human Proteins Associated with Epilepsy
  50. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
  51. Predictors and dynamics of postpartum relapses in women with multiple sclerosis
  52. Peptide matching between Epstein-Barr virus and human proteins
  53. Peptide profiling of the route from Mahoney to Sabin, and return
  54. Peptide Sharing Between Influenza A H1N1 Hemagglutinin and Human Axon Guidance Proteins
  55. Confronting JC virus and Homo sapiens biological signatures 
  56. West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses
  57. Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis
  58. Increasing age at disability milestones among MS patients in the MSBase Registry
  59. Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome
  60. A peptide talk between JC virus and the human host: from silent infection to autoimmunity
  61. Impact of Natalizumab on Cognitive Performances and Fatigue in Relapsing Multiple Sclerosis: A Prospective, Open-Label, Two Years Observational Study
  62. Developing an anti-Campylobacter jejunivaccine
  63. Circumscribing the Conformational Peptide Epitope Landscape
  64. How a single amino acid change may alter the immunological information of a peptide
  65. The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry
  66. The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude
  67. Treating multiple sclerosis with natalizumab
  68. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone
  69. Natural History of Multiple Sclerosis: Have Available Therapies Impacted Long-Term Prognosis?
  70. Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide
  71. Charting the peptide crossreactome between HIV-1 and the human proteome
  72. No human protein is exempt from bacterial motifs, not even one
  73. Proposing Low-Similarity Peptide Vaccines againstMycobacterium tuberculosis
  74. Bacterial peptides are intensively present throughout the human proteome
  75. Proteome-guided search for influenza A B-cell epitopes
  76. Massive peptide sharing between viral and human proteomes
  77. Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response
  78. Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes
  79. Sub-epitopic dissection of HCV E1315–328HRMAWDMMMNWSPT sequence by similarity analysis
  80. Peptidology: short amino acid modules in cell biology and immunology
  81. Identification of Monoclonal Anti-HMW-MAA Antibody Linear Peptide Epitope by Proteomic Database Mining
  82. NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope
  83. Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients
  84. Clinical applications of DNA microarray analysis